Historically, SIFI has been a modest local player focused on ophthalmic products, but in recent years the company has set some ambitious goals for…

While Italy’s biotech landscape is generally held to be somewhat immature in comparison to more established markets such as Germany, France or the…

SIFI's Fabrizio Chines outlines how the company is progressing in European ophthalmic markets, explains the added value it is bringing to the glaucoma…

Rafael Salamanca, the founder of Depósito de Drogas Boyacá, shares his insights on the recent developments of the company in the challenging…

From Greece to the world – Rafarm is an example of a local champion in the midst of realizing its global ambitions. Blessed with the duality of a…

"We are witnessing many instances where pharma companies are shrinking to grow.”

Having successfully accomplished a four-year turnaround exercise and with a fresh capital injection from a leading Italian PE firm, SIFI executive…

The Head of Corporate & Institutional Banking of the Mauritius Commercial Bank explains why the diversification of the Mauritian economy into the…

Portuguese pharmaceutical group Bluepharma consists of ten companies that represent different parts of the medicine value chain. The success of…

Portuguese pharmaceutical group Bluepharma consists of ten companies that represent different parts of the medicine value chain. The success of…

Portuguese pharmaceutical group Bluepharma consists of ten companies that represent different parts of the medicine value chain. The success of…